Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2000;101:2185-2192

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Varma, N.
Right arrow Articles by Apstein, C. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Varma, N.
Right arrow Articles by Apstein, C. S.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*CALCIUM COMPOUNDS
*CALCIUM, ELEMENTAL
Related Collections
Right arrow Animal models of human disease

(Circulation. 2000;101:2185.)
© 2000 American Heart Association, Inc.


Basic Science Reports

Increased Diastolic Chamber Stiffness During Demand Ischemia

Response to Quick Length Change Differentiates Rigor-Activated From Calcium-Activated Tension

Niraj Varma, MRCP; Franz R. Eberli, MD; Carl S. Apstein, MD

From the Cardiac Muscle Research Laboratory, Whitaker Cardiovascular Institute, Boston University School of Medicine, Boston, Mass.

Correspondence to Niraj Varma, MRCP, Cardiac Muscle Research Laboratory X720, Boston University School of Medicine, 650 Albany St, Boston MA 02118.


*    Abstract
up arrowTop
*Abstract
down arrowIntroduction
down arrowMethods
down arrowResults
down arrowDiscussion
down arrowReferences
 
Background—Increased diastolic chamber stiffness ({uparrow}DCS) during angina (demand ischemia) has been postulated to be generated by increased diastolic myocyte calcium concentration.

Methods and Results—We reproduced demand ischemia in isolated isovolumically contracting red-cell–perfused rabbit hearts by imposing pacing tachycardia during global low coronary blood flow (32% of baseline). This increased lactate production without increasing oxygen consumption and resulted in {uparrow}DCS (isovolumic left ventricular end-diastolic pressure [LVEDP] increased 10 mm Hg, P<0.001, n=38). To determine the mechanism of {uparrow}DCS, we assessed responses to a quick-stretch-release maneuver (QSR), in which the intraventricular balloon was rapidly inflated and deflated to achieve a 3% circumferential muscle fiber length change. QSR was first validated as an effective method of discriminating between calcium-driven and rigor-mediated {uparrow}DCS. QSR imposed during demand ischemia when DCS had increased (LVEDP pretachycardia versus posttachycardia, 15±1 versus 27±2 mm Hg, P<0.001, n=6) reduced DCS to pretachycardia values (LVEDP post-QSR, 15±1 mm Hg, P<0.001), ie, elicited a response characteristic of rigor, without any component of calcium-generated tension.

Conclusions—A rigor force, possibly resulting from high-energy phosphate depletion and/or an increase in ADP, appears to be the primary mechanism underlying increased DCS in this model of global LV demand ischemia.


Key Words: diastole • angina • rigor


*    Introduction
up arrowTop
up arrowAbstract
*Introduction
down arrowMethods
down arrowResults
down arrowDiscussion
down arrowReferences
 
Increased diastolic chamber stiffness during angina manifests as an increase in left ventricular end-diastolic pressure (LVEDP)1 2 relative to LV volume3 and has been reproduced in animal models by pacing tachycardia imposed during regional4 or global5 low-flow ischemia. Diastolic persistence of increased intracellular calcium has been postulated to be the responsible mechanism.6 In other experimental ischemic states, some data support a calcium-driven mechanism for increased diastolic tension,7 8 but other data support a mechanism of rigor, resulting from decreased ATP,9 10 11 possibly in conjunction with increased ADP.12 13 14

Here, in a model using isolated hearts subjected to global demand ischemia, we used a myocardial quick-stretch-release (QSR) maneuver to discriminate rigor from calcium-activated tension.15 16 QSR imposed during diastolic dysfunction resulting from demand ischemia elicited responses characteristic of a pure rigor-bond–mediated increase in tension, suggesting that a calcium-mediated tension was not involved.


*    Methods
up arrowTop
up arrowAbstract
up arrowIntroduction
*Methods
down arrowResults
down arrowDiscussion
down arrowReferences
 
The experimental preparation has been described in detail previously.17 Notably, we used an isolated, isovolumic (balloon-in-LV) red-cell–perfused rabbit heart preparation (37°C). Diastolic chamber stiffness was indexed by isovolumic LVEDP,5 17 and myocardial oxygen consumption, lactate assays, and tissue levels of ATP were derived as before.17

Quick-Stretch-Release
Quick alterations in LV balloon volume were performed by a moving piston driven by compressed air that could deliver and withdraw the same aliquot of fluid into and out of the intraventricular balloon in 0.5 second. The volume was varied precisely for each individual heart to equal 25% of the baseline balloon volume, corresponding to a circumference increment of {approx}3%.

Animals received humane care in compliance with the "Principles of Laboratory Animal Care" formulated by the National Society for Medical Research and the Guide for Care and Use of Laboratory Animals prepared by the National Academy of Sciences (NIH publication 85-23, revised 1985).

Experimental Protocols
Stabilization Period
During initial stabilization (30 minutes), all hearts were perfused at a constant coronary flow rate that elicited a coronary perfusion pressure of 80 mm Hg (normoxia) and paced at a "physiological" resting rate of 3 Hz. The LV balloon volume was adjusted to achieve a stable LVEDP of 20 mm Hg. This relatively high LVEDP was selected because (1) a high LVEDP is frequent in heart failure associated with coronary artery disease; (2) the heart is functioning on the steep part of the pressure-volume curve, and any changes in diastolic chamber stiffness might be more apparent; and (3) a higher LVEDP producing an increase in wall stress served to enhance the metabolic demand aspect of this model.

Demand Ischemia
Demand ischemia was reproduced by imposition of combined ischemia and tachycardia to increase metabolic demand (n=38).

To impose ischemia, coronary blood flow was reduced to achieve a coronary perfusion pressure of 20 mm Hg, and flow was then held constant at this level. This degree of coronary perfusion pressure is comparable to the perfusion pressure distal to severe coronary stenoses in patients with angina.18

To increase metabolic demand, the pacing rate was increased to 7 Hz, ie, tachycardia. When isovolumic LVEDP had risen 10 mm Hg above the pretachycardia level, indicating a physiologically significant increase in diastolic chamber stiffness, tachycardia was terminated (pacing rate returned to 3 Hz), but reduced coronary flow (at a constant rate) continued. Then, to demonstrate reversibility of increased diastolic chamber stiffness, coronary flow was returned to baseline rates 5 minutes after tachycardia termination (n=7).

Two separate control groups were studied to validate the above model of demand ischemia. Hearts in 1 group, tachycardia without ischemia, underwent 30 minutes of tachycardia (7 Hz) while coronary blood flow was allowed to increase to maintain a constant coronary perfusion pressure of 80 mm Hg, ie, increased metabolic demand without accompanying ischemia (n=6). In the other group, ischemia without tachycardia, hearts underwent 30 minutes of underperfusion at a constant coronary flow rate that elicited a coronary perfusion pressure of 20 mm Hg while pacing was continued at a baseline rate of 3 Hz, ie, no increased metabolic demand was imposed (n=6).

To determine whether an increase in LVEDP was related to reduced [ATP], ATP content in hearts subjected to demand ischemia (n=5) and freeze-clamped when LVEDP had increased 10 mm Hg was compared with that in hearts subjected to ischemia without tachycardia (n=5) and freeze-clamped at time points matched to an equivalent duration of ischemia for each heart in the demand ischemia group.

In all experiments, hemodynamic and metabolic measurements were obtained every 5 minutes.

Quick-Stretch-Release
First, QSR was delivered at baseline to assess whether the maneuver itself would have any effects on function (normoxia, n=7). Then, QSR was validated as an effective method of distinguishing between rigor-mediated and calcium-driven increases in diastolic chamber stiffness in the isolated heart. Rigor contracture was created by imposing sustained zero-flow ischemia after initial stabilization (zero-flow ischemia, n=6).10 When LVEDP had increased {approx}10 mm Hg, QSR was performed.

QSR was then performed in a model in which increased diastolic chamber stiffness was produced by a mechanism known to be generated by diastolic calcium persistence (n=6). After initial stabilization, LV balloon volume was adjusted to produce an LVEDP of 16±1 mm Hg, but thereafter volume was not changed. An intracoronary infusion of 5 mmol/L caffeine and 5 mmol/L calcium chloride was then commenced under normoxic conditions. Caffeine impairs sarcoplasmic reticular calcium reuptake and increases intracellular diastolic calcium, resulting in slowed and incomplete relaxation. In the presence of caffeine, calcium involved in continued contractile activity is handled predominantly by the sodium-calcium exchanger.19 20 Additional calcium loading during caffeine exposure further increased diastolic chamber stiffness. When isovolumic LVEDP had increased {approx}10 mm Hg, QSR was performed, and then calcium and caffeine infusions were terminated.

Finally, to elucidate the mechanism of increased diastolic tension in demand ischemia, QSR was applied during the prolonged diastole immediately after tachycardia termination when LVEDP had increased {approx}10 mm Hg during the demand ischemia protocol described above (demand ischemia, n=6).

Statistical Analysis
Data are reported as the mean±SEM. Data acquired by repeated sequential measurements in individual hearts were tested by ANOVA for repeated measures. Statistical comparisons between groups were performed by 2-way ANOVA. If overall ANOVA indicated a significant difference of groups, trials, or interaction, values at specific time points were examined by the method of least significant differences. A value of P<0.05 was considered significant.


*    Results
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMethods
*Results
down arrowDiscussion
down arrowReferences
 
Demand Ischemia
Hemodynamic Characteristics
In hearts subjected to demand ischemia (n=38), a decrease in coronary perfusion pressure from 80 to 20 mm Hg (reduction in coronary blood flow from 1.05±0.03 to 0.34±0.01 mL · min-1 · g LV wet wt-1, P<0.001) reduced LV systolic pressure (LVSP) from 123±2 to 63±2 mm Hg (P<0.001) and LVEDP from 20 to 17±1 mm Hg (P<0.001), representing a loss in coronary vascular turgor (Figures 1Down and 2aDown).21 Results from a typical experiment are illustrated in Figure 1Down. Imposition of tachycardia caused an immediate small increase in isovolumic LVEDP (incomplete relaxation), followed by a more gradual increase in LVEDP. A rise in LVEDP occurred in all hearts (mean, 15.3±0.9 minutes per 10 mm Hg increase). After LVEDP had increased 10 mm Hg, tachycardia was terminated (pacing rate returned to 3 Hz), but coronary flow continued at its ischemic level. In this phase, LVEDP remained elevated by 7±1 mm Hg compared with pretachycardia levels (P<0.001), representing a stable increase in diastolic chamber stiffness resulting from increased metabolic demand during low-flow perfusion.



View larger version (48K):
[in this window]
[in a new window]
 
Figure 1. Demand ischemia. Imposing ischemia (decreasing coronary perfusion pressure [CPP] to 20 mm Hg) decreased LVSP to 71 mm Hg and LVEDP from 20 to 18 mm Hg. Tachycardia (arrow) resulted in a gradual increase in isovolumic LVEDP, indicative of increasing diastolic chamber stiffness. LV developed pressure (LVSP minus LVEDP) was diminished by onset of tachycardia but then stabilized. Tachycardia was terminated when LVEDP had increased 10 mm Hg, ie, from 18 to 28 mm Hg. After cessation of tachycardia and first spontaneous beat (*), LVEDP remained elevated at 24 mm Hg, ie, a net postdemand ischemia increase in LVEDP of 6 mm Hg in this example, representing a state of sustained ischemic diastolic dysfunction.



View larger version (15K):
[in this window]
[in a new window]
 
Figure 2. Comparison of demand ischemia ({blacksquare}), tachycardia without ischemia ({circ}), and ischemia without tachycardia ({triangleup}). n=6 per group. See text for details. *P<0.001; {dagger}P<0.025.

Reversibility
In hearts undergoing reperfusion (n=7), LVEDP returned to baseline (22±2 mm Hg) and LVSP recovered (88±4 mm Hg) within 5 minutes, indicating the rapidly reversible nature of the ischemic increase in diastolic chamber stiffness.

Hearts subjected to tachycardia without ischemia or to ischemia without tachycardia demonstrated no significant increase in LVEDP (Figure 2aUp). Thus, neither tachycardia alone nor low-flow ischemia alone was sufficient, but the combination, ie, demand ischemia, resulted in increased diastolic chamber stiffness.

Metabolic Characteristics
With the onset of ischemia (demand ischemia and ischemia without tachycardia groups), hearts switched from net myocardial lactate consumption to net lactate production (Figure 2bUp and 2cUp). In ischemia without tachycardia, lactate production then remained constant. In contrast, in demand ischemia, tachycardia further increased lactate production (demand ischemia, 0.45±0.03 versus ischemia without tachycardia, 0.12±0.03 [µmol/L] · mL-1 · min-1 · g LV wet wt-1, P<0.005). Lactate production was also greater in demand ischemia than in hearts subjected to tachycardia without ischemia.

Oxygen consumption decreased in both demand ischemia and ischemia without tachycardia. Imposition of tachycardia in demand ischemia did not alter oxygen consumption. In tachycardia without ischemia oxygen, conversely, consumption increased during tachycardia. Hence, hearts in demand ischemia in which coronary flow was restricted were unable to increase oxygen consumption when energy demand was increased by tachycardia, in contrast to the group in which coronary flow was allowed to increase commensurately with increased metabolic demand.

ATP Content
We have previously reported a baseline ATP content of 18.01±2.00 µmol/L ATP/g LV dry wt in this experimental preparation.17 Hearts subjected to demand ischemia (isovolumic LVEDP pretachycardia versus posttachycardia [15±2 minutes], 17±1 versus 26±1 mm Hg, P<0.001) had an ATP content of 9.12±1.76 (µmol/L)/g LV dry wt, ie, a 50% reduction at the point at which LVEDP had increased 10 mm Hg. In ischemia without tachycardia (ischemia duration, 14±3 minutes), LVEDP remained unaltered, and ATP content was 10.78±0.94 (µmol/L)/g LV dry wt (P=NS versus demand ischemia). Thus, these 2 groups did not differ in end-ischemic [ATP], despite the imposition of tachycardia and the development of increased diastolic chamber stiffness in the demand ischemia group.

Quick-Stretch-Release
Groups of hearts in which QSR was performed had similar baseline hemodynamic characteristics before interventions were performed (Figures 3 through 7DownDownDownDownDown). QSR at baseline (normoxia, n=7) did not affect function (pre-QSR versus post-QSR LVEDP, 20±1 versus 19±1 mm Hg, P=NS; LVSP, 122±3 versus 121±4 mm Hg, P=NS) (Figure 3Down).



View larger version (29K):
[in this window]
[in a new window]
 
Figure 3. QSR at baseline. Coronary artery perfusion pressure (CPP) was 85 mm Hg (normoxia). LVEDP before and immediately after QSR was 20 mm Hg, ie, unaffected. LVSP and differentiated pressure (dP/dt) increased slightly for a few cycles after QSR before returning to baseline.



View larger version (28K):
[in this window]
[in a new window]
 
Figure 4. QSR during classic rigor. Zero-flow ischemia (coronary perfusion pressure [CPP] of zero) resulted in contractile failure (LVSP of zero). An initial reduction in LVEDP from 20 to 17 mm Hg was followed by a progressive increase, ie, increased diastolic chamber stiffness due to rigor contracture. When LVEDP had increased from 17 to 27 mm Hg, QSR caused immediate reduction to 17 mm Hg, ie, LVEDP returned to precontracture values. Note different paper speeds. During development of contracture, speed is 0.05 mm/s.



View larger version (24K):
[in this window]
[in a new window]
 
Figure 5. QSR during a calcium-driven increase in diastolic chamber stiffness. Caffeine and calcium (Ca2+) during normoxic perfusion (coronary perfusion pressure [CPP] 80 mm Hg) increased contractile function (LVSP increased from 110 to 120 mm Hg and isovolumic LVEDP from 12 to 25 mm Hg). LVEDP was unaffected by QSR but immediately decreased to 13 mm Hg when infusions were terminated.



View larger version (18K):
[in this window]
[in a new window]
 
Figure 6. QSR during demand ischemia. Ischemia (coronary perfusion pressure [CPP] 20 mm Hg) decreased LVSP to 61 mm Hg and LVEDP to 14 mm Hg. Tachycardia increased isovolumic LVEDP from 14 to 26 mm Hg, ie, increased diastolic chamber stiffness. QSR imposed after tachycardia immediately reduced LVEDP to 14 mm Hg, ie, to precontracture values.



View larger version (21K):
[in this window]
[in a new window]
 
Figure 7. Summary of effects of QSR on increased diastolic tension (isovolumic LVEDP) in 3 groups: rigor contracture (•, n=6), calcium 5 mmol/L + caffeine 5 mmol/L ({circ}, n=6), and demand ischemia ({blacksquare}, n=6). In all 3, there is a similar increase in LVEDP from 15 to 26 mm Hg. At peak, QSR resulted in no change in calcium 5 mmol/L + caffeine 5 mmol/L group but had a similar effect in rigor contracture and demand ischemia, ie, elevated LVEDP returned to precontracture values.

With zero-flow ischemia (n=6), hearts rapidly became asystolic and LVEDP initially decreased (16±1 mm Hg) (Figure 4Up; Reference 21 ). During sustained ischemia (18±4 minutes), LVEDP progressively increased, resulting in ischemic contracture ("classic rigor"10 ). QSR at this point instantly lysed this rigor tension (LVEDP pre-QSR versus post-QSR, 27±1 versus 17±1 mm Hg, P<0.001), ie, LV diastolic pressure decreased to precontracture values with no tension recovery.

When increased diastolic chamber stiffness occurring from increased cytosolic diastolic calcium was created by intracoronary infusion of caffeine and calcium chloride (n=6, Figure 5Up), LVEDP increased from a baseline of 16±1 to 28±1 mm Hg (P<0.001). QSR imposed at this point had no effect on increased diastolic tension or systolic function (pre-QSR versus post-QSR: LVEDP, 27±1 versus 26±1 mm Hg, P=NS; LVSP, 111±5 versus 109±5 mm Hg, P=NS). LVEDP, however, returned to baseline values on termination of infusion. Hence, the different responses of increased LVEDP to QSR between rigor bonds in classic rigor compared with a calcium-driven mechanism validated QSR as a method of discriminating rigor- versus calcium-mediated increases in diastolic chamber stiffness.

In demand ischemia, tachycardia was terminated after LVEDP had increased from 15±1 to 27±2 mm Hg (P<0.001, n=6). QSR subsequent to tachycardia immediately lysed increased diastolic tension (LVEDP pre-QSR versus post-QSR, 27±2 versus 15±1 mm Hg, P<0.001), ie, chamber stiffness returned to baseline (Figure 6Up). The decrement of LVEDP produced by QSR was identical in magnitude to the upward shift of isovolumic LVEDP sustained during pacing tachycardia. Hence, QSR during demand ischemia elicited a response similar to that with rigor contracture associated with zero-flow ischemia but unlike that with calcium-activated increased diastolic tension (Figure 7Up).


*    Discussion
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMethods
up arrowResults
*Discussion
down arrowReferences
 
The acute and reversible decrease in diastolic distensibility during angina due to sustained actin-myosin interaction during diastole may be related to myocardial ATP depletion (with a concomitant increase in ADP) resulting in rigor, to diastolic persistence of an increased intracellular calcium concentration, or to a combination of the 2. In the present study using a model simulating some of the features of demand ischemia during angina, responses to quick length changes support a rigor mechanism, without involvement of a calcium-driven tension.

In this model, we reproduced reversible diastolic dysfunction with demand ischemia: isovolumic LVEDP increased with combined low-flow ischemia and tachycardia but not with either ischemia or tachycardia alone and was characterized by increased lactate production with an inability to increase oxygen consumption (Figures 1Up and 2Up). Here, the globally ischemic LV served to model the regionally ischemic region in a patient with angina or a large-animal model with single coronary artery stenosis. This, by imposing homogeneous conditions throughout the LV, facilitated determination of mechanisms underlying diastolic dysfunction. However, reduction of coronary artery perfusion pressure before tachycardia, with a marked global reduction in coronary artery flow, resulted in profound contractile dysfunction. Systolic dysfunction of this degree does not usually accompany regional ischemia or angina unless there is also severe global ischemia, eg, left main or 3-vessel disease, severe aortic stenosis, or systemic hypotension and tachycardia. Hence, our model does not simulate all the hemodynamic features observed during regional demand ischemia in humans or large-animal models (in which resting coronary flow in a stenotic segment and contractile function may remain unchanged), and this limitation prevents direct extrapolation of our results to clinical angina.

Quick-Stretch-Release
The QSR maneuver, in which a sudden increment (1% to 10%) in length is followed by a rapid return to baseline length, has been used to distinguish between calcium-activated and rigor tension in unstimulated skeletal16 and papillary15 muscle. After QSR, rigor bonds are characterized by tension lysis and by failure of immediate tension redevelopment, so that poststretch tension remains markedly reduced relative to the prestretch level. In contrast, QSR imposed on muscle with continuous calcium-activated cross-bridge cycling is followed by incomplete lysis and by a rapid redevelopment of tension to its prestretch value.

Here, QSR was similarly applied in the actively contracting isolated heart without deleterious effects (Figure 3Up). During tonic contracture due to classic ischemic rigor, QSR caused immediate, complete, and sustained lysis of diastolic tension (Figure 4Up), but when an increase in diastolic chamber stiffness was driven by diastolic persistence of calcium, QSR failed to alter diastolic tension (Figure 5Up).

Thus, we could examine effects of QSR under specific conditions in which diastolic dysfunction occurred in contracting hearts. We hypothesized that in demand ischemia, if increased LVEDP were produced by persistent cross-bridge cycling, equivalent to a state of sustained partial systole due to diastolic persistence of increased calcium, then QSR would cause no significant lysis of diastolic tension. Conversely, if rigor force were responsible, QSR should effectively lyse this tension. If a combination of these mechanisms were operative, then an intermediate response would be predicted. In our model, QSR produced complete lysis of increased diastolic tension resulting from demand ischemia, a behavior typical of rigor without any component of a calcium-driven tension (Figures 6Up and 7Up).

Subcellular Mechanisms of Increased Diastolic Tension
The subcellular mechanisms underlying increased chamber stiffness in demand ischemia have received relatively little study. One report proposed a mechanism of increased diastolic myocyte calcium concentration based on the observation that exposure to caffeine during the last 30 seconds of pacing tachycardia exacerbated the degree of increased diastolic chamber stiffness sustained during demand ischemia.6 However, this conclusion is confounded because caffeine itself may have contributed importantly to cytosolic calcium overload. For example, increased diastolic chamber stiffness can occur in normoxic hearts on exposure to caffeine: in our experimental model (Figure 5Up), caffeine increased LVEDP, which was further exaggerated by superimposed calcium loading. Thus, the observation that caffeine augmented an increase in ischemic diastolic stiffness does not prove that the initial ischemia-induced increase in stiffness itself was calcium-driven.

In contrast, many previous studies have investigated the mechanism of ischemic contracture in a variety of models, eg, hearts in situ or subjected to hypoxia or zero-flow ischemia, or isolated muscle strips or myocytes subjected to metabolic inhibition. Under these conditions, an increase in diastolic calcium level has been widely reported,7 8 consistent with a calcium-driven mechanism for the contracture. This remains an appealing explanation, although no cause-and-effect relation has been definitively established. Others report no correlation between increased myocyte calcium and increased diastolic tension9 22 and favor an alternative mechanism of rigor.9 10 11 23 These models, however, comprise a heterogeneous group of ischemic states, and their results may not be readily extrapolated to the demand ischemia of clinical angina.

Our result of diastolic tension lysis by QSR during demand ischemia supports a rigor mechanism secondary to ATP depletion as the basis of increased diastolic chamber stiffness. However, we could not demonstrate a lower average tissue [ATP] in hearts subjected to demand ischemia (in which an increase in diastolic chamber stiffness occurred) compared with hearts subjected to similar ischemia but without tachycardia, in which no increase in diastolic tension occurred. In both groups, [ATP] decreased by only 50%. Thus, we could not correlate the increase in ischemic diastolic tension with total tissue ATP depletion.

However, these ATP measurements do not rule out rigor tension as the mechanism for the increase in ischemic diastolic chamber stiffness. Rigor tension may be generated in the presence of only modest reductions in [ATP] when [ADP] increases12 13 14 and may be correlated with increased diastolic stiffness.14 We cannot be certain, however, that [ADP] increased in this demand ischemia model, because it did not increase significantly in other studies of low-flow ischemia from our laboratory.24 Nevertheless, even severe ATP depletion occurring in only a small group of myocytes would be undetected by measurements of total tissue [ATP]. During demand ischemia, a population of more severely energy-deprived myocytes vulnerable to rigor may be interspersed among normally contracting cells. Experiments in isolated myocytes have consistently demonstrated inexcitability and contractile failure at the time of rigor shortening.25 Thus, in the isolated heart undergoing demand ischemia, the continued development of phasic contractile force when diastolic pressure is elevated is consistent with the idea that some myocytes are not in a rigor state and are capable of contracting, whereas others are in a rigor state and are inexcitable. In isolated hearts, cell-by-cell electron microscopy revealed a highly heterogeneous distribution of development of ischemic contracture when diastolic chamber stiffness had increased during low-flow ischemia.26 The extent of diastolic chamber stiffness increase may be related to the number of myocytes in rigor, which may progressively increase with continued demand ischemia (Figure 1Up). Contracture may be reversible, as demonstrated here when the supply-demand mismatch was corrected and as observed during reoxygenation of anoxic myocytes.22

Characteristics of the Model
Our experimental preparation confers many advantages for modeling demand ischemia. The right ventricle is decompressed and the pericardium freed, which eliminates interactions with the LV. The heart is subjected to global underperfusion, which prevents the confounding mechanical influence of dyssynchronous contraction of ischemic and nonischemic segments associated with regional ischemia. The isovolumic preparation allows the use of QSR as an investigative tool. Use of a red-cell perfusate at 37°C containing glucose (5.5 mmol/L) and free fatty acid at a normal ratio of FFA to albumin provides normal levels of the major myocardial substrates and ensures a normal rate of oxygen delivery at physiological coronary flow rates. Elucidation of diastolic dysfunction during demand ischemia in isolated heart appears to require a critical interplay and relationship between coronary flow, energy supply, and energy demand. For example, we have found it impossible to reproduce demand ischemia–induced increases in LVEDP in hearts perfused with crystalloid solutions or at temperatures <37°C.

In summary, in this model of demand ischemia in the isolated heart in which we simulated features of diastolic anginal physiology, responses to quick length changes supported a mechanism of a reversible rigor-like tension underlying increased diastolic chamber stiffness and not a calcium-driven force.


*    Acknowledgments
 
This research was supported in part by US Public Health Service grant HL-48175. Dr Varma is a recipient of a Physician-Investigator fellowship of the Massachusetts Affiliate of the American Heart Association (13-614-923).

Received October 7, 1999; revision received December 13, 1999; accepted December 22, 1999.


*    References
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMethods
up arrowResults
up arrowDiscussion
*References
 

  1. Carroll JD, Hess OM, Hirzel HO, Krayenbuehl HP. Exercise-induced ischemia: the influence of altered relaxation on early diastolic pressures. Circulation. 1983;67:521–528.[Abstract/Free Full Text]
  2. Barry WH, Brooker JZ, Alderman EL, Harrison DC. Changes in diastolic stiffness and tone of the left ventricle during angina pectoris. Circulation. 1974;49:255–263.[Abstract/Free Full Text]
  3. Aroesty JM, McKay RG, Heller GV, Royal HD, Als AV, Grossman W. Simultaneous assessment of left ventricular systolic and diastolic dysfunction during pacing-induced ischemia. Circulation. 1985;71:889–900.[Abstract/Free Full Text]
  4. Serizawa T, Carabello BA, Grossman W. Effect of pacing-induced ischemia on left ventricular diastolic pressure-volume relations in dogs with coronary stenoses. Circ Res. 1980;46:430–439.[Free Full Text]
  5. Isoyama S, Apstein CS, Wexler LF, Grice WN, Lorell BH. Acute decrease in left ventricular diastolic chamber distensibility during simulated angina in isolated hearts. Circ Res. 1987;61:925–933.[Abstract/Free Full Text]
  6. Paulus WJ, Serizawa T, Grossman W. Altered left ventricular diastolic properties during pacing-induced ischemia in dogs with coronary stenoses: potentiation by caffeine. Circ Res. 1982;50:218–227.[Free Full Text]
  7. Kihara Y, Grossman W, Morgan JP. Direct measurement of changes in [Ca2+]i during hypoxia, ischemia, and reperfusion of the intact mammalian heart. Circ Res. 1989;65:1029–1044.[Abstract/Free Full Text]
  8. Barry WH, Ikenouchi H. Does calcium overload adequately explain diastolic dysfunction during metabolic inhibition? In: Lorell BH, Grossman W, eds. Diastolic Relaxation of the Heart. Boston, Mass: Kluwer Academic Publishers; 1994:135–148.
  9. Koretsune Y, Marban E. Mechanism of ischemic contracture in ferret hearts: relative roles of [Ca2+]i elevation and ATP depletion. Am J Physiol. 1990;258:H9–H16.[Abstract/Free Full Text]
  10. Hearse DJ. Oxygen deprivation and early myocardial contractile failure: a reassessment of the possible role of adenosine triphosphate. Am J Cardiol. 1979;44:1115–1121.[Medline] [Order article via Infotrieve]
  11. Bowers KC, Allshire AP, Cobbold PH. Bioluminescent measurement in single cardiomyocytes of sudden cytosolic ATP depletion coincident with rigor. J Mol Cell Cardiol. 1991;24:213–218.
  12. Ventura-Clapier R, Veksler V. Myocardial ischemic contracture: metabolites affect rigor tension development and stiffness. Circ Res. 1994;74:920–929.[Abstract/Free Full Text]
  13. Yamashita H, Sata M, Sugiura S, Momomura S, Serizawa T, Iizuka M. ADP inhibits the sliding velocity of fluorescent actin filaments on cardiac and skeletal myosins. Circ Res. 1994;74:1027–1033.[Abstract/Free Full Text]
  14. Tian R, Christe ME, Spindler M, Hopkins JCA, Halow JM, Camacho SA, Ingwall JS. Role of MgADP in the development of diastolic dysfunction in the intact beating rat heart. J Clin Invest. 1997;99:745–751.[Medline] [Order article via Infotrieve]
  15. Ventura-Clapier R, Vassort G. Rigor tension during metabolic and ionic rises in resting tension in rat hearts. J Mol Cell Cardiol. 1981;13:551–561.[Medline] [Order article via Infotrieve]
  16. Heinl P, Kuhn HJ, Ruegg JC. Tension responses to quick length changes of glycerinated skeletal muscle fibres from the frog and tortoise. J Physiol. 1974;237:243–258.[Abstract/Free Full Text]
  17. Eberli FR, Weinberg EO, Grice WN, Horowitz GL, Apstein CS. Protective effect of increased glycolytic substrate against systolic and diastolic dysfunction and increased coronary resistance from prolonged global underperfusion and reperfusion in isolated rabbit hearts perfused with erythrocyte suspensions. Circ Res. 1991;68:466–481.[Abstract/Free Full Text]
  18. Gould KL, Lipscomb K. Effects of coronary stenoses on coronary flow reserve and resistance. Am J Cardiol. 1974;34:48–55.[Medline] [Order article via Infotrieve]
  19. Puglisi JL, Bassani RA, Bassani JWM, Amin JA, Bers DM. Temperature and relative contributions of calcium transport systems in cardiac myocyte relaxation. Am J Physiol. 1996;270:H1772–H1778.[Abstract/Free Full Text]
  20. Bassani RA, Bassani JWM, Bers DM. Mitochondrial and sarcolemmal Ca++ transport reduce [Ca++]i during caffeine contractures in rabbit cardiac myocytes. J Physiol. 1992;453:591–608.[Abstract/Free Full Text]
  21. Apstein CS, Grossman W. Opposite initial effects of supply and demand ischemia on left ventricular diastolic compliance: the ischemia-diastolic paradox. J Mol Cell Cardiol. 1987;19:119–128.[Medline] [Order article via Infotrieve]
  22. Allshire A, Piper HM, Cuthbertson KSR, Cobbold PH. Cytosolic free Ca2+ in single rat heart cells during anoxia and reoxygenation. Biochem J. 1987;244:381–385.[Medline] [Order article via Infotrieve]
  23. Lewis MJ, Housmans PR, Claes VA, Brutsaert DC, Henderson AH. Myocardial stiffness during hypoxic and reoxygenation contracture. Cardiovasc Res. 1980;14:339–344.[Medline] [Order article via Infotrieve]
  24. Cave AC, Ingwall JS, Friedrich J, Liao R, Saupe KW, Apstein CS, Eberli FR. ATP synthesis during low-flow ischemia: influence of increased glycolytic substrate. Circulation. In press.
  25. Ikenouchi H, Zhao L, Barry WH. Effect of 2,3-butane-dione-monoxime on myocyte resting force during prolonged metabolic inhibition. Am J Physiol. 1994;267:H419–H430.[Abstract/Free Full Text]
  26. Apstein CS, Gravino FN, Haudenschild CC. Determinants of a protective effect of glucose and insulin on the ischemic myocardium: effects on contractile function, diastolic compliance, metabolism, and ultrastructure during ischemia and reperfusion. Circ Res. 1983;52:515–526.[Abstract]



This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
N. Varma, J. P. Morgan, and C. S. Apstein
Mechanisms underlying ischemic diastolic dysfunction: relation between rigor, calcium homeostasis, and relaxation rate
Am J Physiol Heart Circ Physiol, March 1, 2003; 284(3): H758 - H771.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
D. A. Brenner, C. S. Apstein, and K. W. Saupe
Exercise Training Attenuates Age-Associated Diastolic Dysfunction in Rats
Circulation, July 10, 2001; 104(2): 221 - 226.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
N. Varma, F. R. Eberli, and C. S. Apstein
Left ventricular diastolic dysfunction during demand ischemia: rigor underlies increased stiffness without calcium-mediated tension. Amelioration by glycolytic substrate
J. Am. Coll. Cardiol., June 15, 2001; 37(8): 2144 - 2153.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Varma, N.
Right arrow Articles by Apstein, C. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Varma, N.
Right arrow Articles by Apstein, C. S.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*CALCIUM COMPOUNDS
*CALCIUM, ELEMENTAL
Related Collections
Right arrow Animal models of human disease